<DOC>
	<DOCNO>NCT02599194</DOCNO>
	<brief_summary>The goal Phase II clinical trial evaluate ability 18F-FSPG diagnose , prognosticate , evaluate response therapy patient wide variety metastatic cancer .</brief_summary>
	<brief_title>18F-FSPG PET/CT Cancer Patients Therapy</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : Correlate uptake 18F-FSPG patient biopsy proven cancer , therapy , evaluate ability 18F-FSPG identify ass response therapy , correlate patient outcome . SECONDARY OBJECTIVES : I . Comparison 18F-FSPG accumulation available image PET/CT ( include limit 18F-FDG , MRI , diagnostic CT. II . Safety tolerability 18F-FSPG . OUTLINE : Patients receive 18F-FSPG 60 minute injection , undergo 18F-FSPG PET/CT start therapy .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Fluorides</mesh_term>
	<criteria>Written inform consent Able complete PET/CT scan without use sedation Females : Of childbearing potential must : Not nurse Have negative serum pregnancy test document within 48 hour prior administration 18F FSPG PET/CT Not childbearing potential must : Physiologically postmenopausal ( cessation menses 1 year ) Surgically sterile ( documented bilateral oophorectomy and/or document hysterectomy ) Histologically confirm cancer advance ; metastatic ; otherwise suitable surgical resection curative intent Scheduled begin therapy The time interval 18F FSPG PET/CT standard care image ( ie , 18F FDG PET/CT , diagnostic CT , MRI ) within 4 week ( exception allow 6 week , option ) Ideally , chemotherapy , radiotherapy , immune/biologic therapy biopsy imaging ( PET/CTs , MRI , diagnostic CTs ) 18F FSPG PET/CT schedule perform ( exception investigator discretion ) No clinically relevant deviation renal function ( serum creatinine &gt; grade 2 Common Terminology Criteria Adverse Events [ CTCAE ] version 4.0 ) ; maximal interval confirmation renal function injection 18F FSPG 1 week Scheduled surgery and/or another invasive procedure ( except biopsy ) within time period 1 month prior 18F FSPG administration Known sensitivity 18F FSPG component preparation Investigator preclude participation scientific reason , reason compliance , reason patient 's safety</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>